These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]. Fléchon A; Biron P; Philip I; Blay JY; Droz JP Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344 [TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy as primary treatment for poor-risk germ-cell tumors: the Memorial Sloan-Kettering experience (1988-1999). Morris MJ; Bosl GJ Int J Cancer; 1999 Dec; 83(6):834-8. PubMed ID: 10597205 [TBL] [Abstract][Full Text] [Related]
13. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955 [TBL] [Abstract][Full Text] [Related]
14. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial. Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience. Saxman SB; Finch D; Gonin R; Einhorn LH J Clin Oncol; 1998 Feb; 16(2):702-6. PubMed ID: 9469360 [TBL] [Abstract][Full Text] [Related]
18. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial. Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194 [TBL] [Abstract][Full Text] [Related]
19. [High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer]. Hasumi H; Kishida T; Teranishi J; Nakaigawa N; Fujinami K; Ikeda I; Uemura H; Yao M; Takeda M; Noguchi S; Kubota Y Hinyokika Kiyo; 2002 Aug; 48(8):469-73. PubMed ID: 12243071 [TBL] [Abstract][Full Text] [Related]
20. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. Motzer RJ; Mazumdar M; Bajorin DF; Bosl GJ; Lyn P; Vlamis V J Clin Oncol; 1997 Jul; 15(7):2546-52. PubMed ID: 9215823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]